Balancing the scale: the role of oral anticoagulants in atrial fibrillation

CPD
By
AP Staff
-

References

  1. Australian Institute of Health and Welfare. Atrial fibrillation in Australia. 2020. At: www.aihw.gov.au/reports/heart-stroke-vascular-diseases/atrial-fibrillation-in-australia/contents/what-is-atrial-fibrillation  
  2. Ball J, Thompson DR, Ski CF, et al. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. Med J Aust 2015;202(1):32–5. 
  3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983–8.
  4. Joglar JA, Mina K, Chung MD, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2024. At: www.jacc.org/doi/10.1016/j.jacc.2023.08.017 
  5. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2024;45(36):3314–414.
  6. Brieger D, Bs M, Connell C, et al. Atrial fibrillation management – the central role of the GP. Medicine Today 2019;20(11)10–16.
  7. Teppo K, Lip GYH, Airaksinen KEJ, et al. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort. Lancet Reg Health Eur 2024;Aug;43:100967.
  8. National Aboriginal Community Controlled Health Organisation and The Royal Australian College of, General Practitioners. National guide to preventive health care for Aboriginal and Torres Strait Islander people Fourth Chapter. 2024. At: www.racgp.org.au/getattachment/ef5164d0-14ce-40b6-bd2e-7fe38922f7d4/National-Guide-to-preventive-healthcare-for-Aboriginal-and-br-Torres-Strait-Islander-people.aspx
  9. RACGP. Guidelines for preventive activities in general practice. 10th edition. 2024. At: www.racgp.org.au/getattachment/52e81aef-5dec-4cf3-a903-fd202246c65f/Guidelines-for-preventive-activities-in-general-practice.aspx
  10. Therapeutic Goods Administration (TGA). Apple Pty Ltd – Cardiac electrophysiology application software. 2022. At: www.tga.gov.au/resources/artg/355992
  11. Brieger D, Amerena J, Attia JR, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Med J Aust 2018;209(8):356–62. At: https://onlinelibrary.wiley.com/doi/abs/10.5694/mja18.00646
  12. Cardiovascular Expert Group. Atrial fibrillation and atrial flutter. In eTG complete. Melbourne: Therapeutic Guidelines; 2024.
  13. Zhu W, Ye Z, Chen S, et al. Comparative effectiveness and safety of non–vitamin k antagonist oral anticoagulants in atrial fibrillation patients. Stroke 2021;52(4):1225–33. At: www.ahajournals.org/doi/10.1161/STROKEAHA.120.031007
  14. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007 Jun 19;146(12):857–67.
  15. NSW Government – Clinical Excellence Commission. DOAC Guidelines. 2025. At: www.cec.health.nsw.gov.au/__data/assets/pdf_file/0005/917807/DOAC-guidelines.pdf
  16. Quality Use of Medicines Alliance. Clinical guide – Anticoagulant management for atrial fibrillation. 2025. At: go.medcast.com.au/anticoagulant-management-atrial-fibrillation-clinical-guide
  17. Livori AC, Dalli L, Nicholls SJ, et al. Defining, measuring, and addressing medication non-adherence in cardiovascular disease. Future Cardiol 2024;1–4. At: www.tandfonline.com/doi/full/10.1080/14796678.2024.2433888